Alberto Ballestrero Selected Research

Multiple Myeloma

12/2023	Complete pathological response of hormone receptor positive invasive breast cancer in a patient with multiple myeloma treated with ixazomib.
3/2016	Evidence for a role of the histone deacetylase SIRT6 in DNA damage response of multiple myeloma cells.
1/2006	The proteasome and its inhibitors in immune regulation and immune disorders.
2/2002	Three-step high-dose sequential chemotherapy in patients with newly diagnosed multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alberto Ballestrero Research Topics

Disease

43	Neoplasms (Cancer) 12/2023 - 03/2003
30	Breast Neoplasms (Breast Cancer) 12/2023 - 12/2003
5	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 03/2003
5	Inflammation (Inflammations) 11/2022 - 11/2012
4	Disease Progression 01/2024 - 02/2010
4	Multiple Myeloma 12/2023 - 02/2002
4	Rectal Neoplasms (Rectal Cancer) 06/2022 - 03/2012
4	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 09/2012
4	Leukemia 11/2015 - 11/2010
3	Residual Neoplasm 01/2020 - 03/2008
3	Adenocarcinoma 01/2020 - 09/2012
3	Lymphoma (Lymphomas) 10/2018 - 02/2004
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017 - 11/2012
3	Hematologic Neoplasms (Hematological Malignancy) 02/2013 - 06/2009
3	Immune System Diseases (Immune Disorders) 01/2013 - 01/2006
2	Colonic Neoplasms (Colon Cancer) 01/2023 - 03/2003
2	COVID-19 11/2022 - 01/2021
2	Carcinoma (Carcinomatosis) 01/2021 - 11/2013
2	Melanoma (Melanoma, Malignant) 05/2019 - 01/2017
2	Heart Failure 01/2019 - 02/2006
2	Infections 01/2019 - 10/2018
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 10/2018 - 12/2016
2	Genomic Instability 03/2016 - 06/2014
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 09/2015 - 11/2010
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2015 - 01/2009
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2010 - 02/2010
2	Renal Cell Carcinoma (Grawitz Tumor) 09/2009 - 03/2003
1	Microsatellite Instability 01/2023
1	Pathologic Complete Response 01/2022
1	Virus Diseases (Viral Diseases) 01/2021
1	Bacterial Pneumonia 01/2021

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 01/2023 - 03/2012
10	NAD (NADH)IBA 01/2017 - 11/2009
9	Hormones (Hormone)IBA 12/2023 - 01/2019
8	Nicotinamide PhosphoribosyltransferaseIBA 01/2017 - 11/2009
7	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 09/2012
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2004
6	EnzymesIBA 11/2020 - 01/2013
5	Proteasome InhibitorsIBA 07/2012 - 04/2005
4	RNA (Ribonucleic Acid)IBA 01/2023 - 03/2003
4	SirtuinsIBA 09/2015 - 01/2011
3	human ERBB2 proteinIBA 01/2023 - 04/2014
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 12/2003
3	InterferonsIBA 11/2022 - 10/2018
3	Messenger RNA (mRNA)IBA 11/2022 - 06/2009
3	Letrozole (Femara)FDA LinkGeneric 11/2022 - 01/2019
3	Squalene Monooxygenase (Squalene Epoxidase)IBA 11/2020 - 01/2016
3	Histone Deacetylases (Histone Deacetylase)IBA 03/2016 - 01/2011
3	Gemcitabine FDA Link 09/2015 - 01/2009
3	N- (4- (1- benzoylpiperidin- 4- yl)butyl)- 3- (pyridin- 3- yl)acrylamideIBA 09/2015 - 06/2009
3	Lapatinib (GW572016)FDA Link 05/2015 - 02/2010
2	Fluorouracil (Carac)FDA LinkGeneric 01/2024 - 03/2014
2	VaccinesIBA 11/2022 - 01/2008
2	Epidermal Growth Factor (EGF)IBA 11/2022 - 03/2015
2	Fulvestrant (Faslodex)FDA Link 01/2022 - 01/2020
2	Tamoxifen FDA LinkGeneric 10/2021 - 01/2020
2	Estrogen ReceptorsIBA 01/2021 - 02/2010
2	bis(p-chlorophenyl)acetic acid (DDA)IBA 01/2021 - 09/2019
2	Transcription Factors (Transcription Factor)IBA 11/2020 - 02/2010
2	CholesterolIBA 11/2020 - 01/2018
2	Capecitabine (Xeloda)FDA Link 01/2020 - 03/2012
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 09/2019 - 09/2015
2	Antiviral Agents (Antivirals)IBA 09/2019 - 10/2018
2	Bevacizumab (Avastin)FDA Link 06/2019 - 03/2012
2	Carboplatin (JM8)FDA LinkGeneric 10/2017 - 01/2009
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2017 - 06/2009
2	Adenosine Triphosphate (ATP)IBA 11/2015 - 11/2010
2	ErbB Receptors (EGF Receptor)IBA 09/2015 - 02/2013
2	Tyrosine Kinase InhibitorsIBA 05/2015 - 03/2010
2	Docetaxel (Taxotere)FDA Link 03/2014 - 10/2011
2	Sirtuin 1IBA 01/2013 - 01/2011
2	CytokinesIBA 11/2012 - 01/2008
2	Bortezomib (Velcade)FDA Link 07/2012 - 01/2006
2	Neoplasm Antigens (Tumor Antigens)IBA 03/2008 - 03/2003
1	Cetuximab (Erbitux)FDA Link 01/2024
1	Leucovorin (Folinic Acid)FDA Link 01/2024
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2024
1	Bendamustine Hydrochloride FDA Link 12/2023
1	Protease Inhibitors (Protease Inhibitor)IBA 12/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2023
1	ixazomibIBA 12/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023
1	mRNA VaccinesIBA 11/2022
1	ribociclibIBA 11/2022
1	palbociclibIBA 01/2022
1	Thymidine KinaseIBA 01/2022
1	Cell-Free Nucleic AcidsIBA 07/2021
1	Immune Checkpoint InhibitorsIBA 07/2021
1	Fluconazole (Zonal)FDA LinkGeneric 01/2021
1	GlucansIBA 01/2021

Therapy/Procedure

13	Therapeutics 01/2024 - 06/2005
10	Drug Therapy (Chemotherapy) 01/2022 - 02/2002
6	Neoadjuvant Therapy 01/2022 - 11/2013
6	Radiotherapy 01/2021 - 02/2004
4	Immunotherapy 07/2021 - 01/2008
2	Transplantation 04/2014 - 01/2008
1	Aftercare (After-Treatment) 12/2023
1	Adjuvant Chemotherapy 01/2023
1	Critical Care (Surgical Intensive Care) 11/2022
1	Laparotomy 06/2022